Log In
Print
BCIQ
Print
Print this Print this
 

firategrast (SB-683699) (formerly T-0047)

Also known as: 683699

  Manage Alerts
Collapse Summary General Information
Company GlaxoSmithKline plc
DescriptionDual integrin alpha(4) antagonist
Molecular Target Integrin alpha(4) (VLA-4 ) (CD49D)
Mechanism of ActionBinds integrin alpha(4)
Latest Stage of DevelopmentPhase II
IndicationMultiple sclerosis (MS)
Partner

Mitsubishi Tanabe Pharma Corp.
 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today